| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
371,150,000 |
| Market
Cap: |
475.07(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.9216 - $2.06 |
|
| Level
I Sector: |
Information Technology |
| Level
II Sector: |
Electronics |
| Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 22.5 |
| Insider 6 Months : 24.8 |
| Insider 3/6 Months : 47.3 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Standard BioTool creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents and software that are used by researchers and clinical labs worldwide. Co. markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Preparation, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. Co.'s product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
11,225,000 |
12,708,220 |
17,529,179 |
27,127,624 |
| Total Buy Value |
$14,436,519 |
$16,303,020 |
$21,437,341 |
$39,926,353 |
| Total People Bought |
3 |
3 |
3 |
4 |
| Total Buy Transactions |
15 |
24 |
25 |
49 |
| Total Shares Sold |
0 |
0 |
58,089 |
58,089 |
| Total Sell Value |
$0 |
$0 |
$57,509 |
$57,509 |
| Total People Sold |
0 |
0 |
3 |
3 |
| Total Sell Transactions |
0 |
0 |
9 |
9 |
| End Date |
2025-10-02 |
2025-07-01 |
2024-12-31 |
2024-01-01 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Casdin Eli |
Director |
– • • |
2025-12-04 |
4 |
B |
$1.45 |
$217,020 |
I/I |
150,000 |
72,100,000 |
2.25 |
-11% |
|
| Casdin Eli |
Director |
– • • |
2025-12-03 |
4 |
B |
$1.44 |
$108,038 |
I/I |
75,000 |
71,950,000 |
2.25 |
-11% |
|
| Casdin Eli |
Director |
– • • |
2025-12-02 |
4 |
B |
$1.42 |
$177,513 |
I/I |
125,000 |
71,875,000 |
2.25 |
-10% |
|
| Casdin Private Growth Equity Fund, L.p. |
Director |
– • – |
2025-11-25 |
4 |
B |
$1.30 |
$9,838,405 |
I/I |
7,550,000 |
71,750,000 |
2.1 |
-10% |
|
| Casdin Private Growth Equity Fund, L.p. |
Director |
– • – |
2025-11-24 |
4 |
B |
$1.43 |
$214,875 |
I/I |
150,000 |
64,200,000 |
2.1 |
-10% |
|
| Kim Hanjoon Alex |
Chief Financial Officer |
• – – |
2025-11-20 |
4 |
D |
$1.28 |
$16,306 |
D/D |
(12,739) |
2,415,086 |
|
- |
|
| Egholm Michael |
President & CEO |
• • – |
2025-11-20 |
4 |
D |
$1.28 |
$81,317 |
D/D |
(63,529) |
5,617,837 |
|
- |
|
| Mackay Sean |
SVP & Chief Business Officer |
• – – |
2025-11-20 |
4 |
D |
$1.28 |
$25,166 |
D/D |
(19,661) |
779,835 |
|
- |
|
| Casdin Eli |
Director |
– • • |
2025-11-20 |
4 |
B |
$1.30 |
$586,260 |
I/I |
450,000 |
64,050,000 |
2.25 |
- |
|
| Casdin Eli |
Director |
– • • |
2025-11-19 |
4 |
B |
$1.28 |
$448,910 |
I/I |
350,000 |
63,600,000 |
2.25 |
- |
|
| Casdin Eli |
Director |
– • • |
2025-11-18 |
4 |
B |
$1.23 |
$339,405 |
I/I |
275,000 |
63,250,000 |
2.25 |
3% |
|
| Casdin Eli |
Director |
– • • |
2025-11-17 |
4 |
B |
$1.22 |
$275,580 |
I/I |
225,000 |
62,975,000 |
2.25 |
6% |
|
| Casdin Eli |
Director |
– • • |
2025-11-14 |
4 |
B |
$1.24 |
$309,800 |
I/I |
250,000 |
62,750,000 |
2.25 |
3% |
|
| Casdin Eli |
Director |
– • • |
2025-11-13 |
4 |
B |
$1.20 |
$541,395 |
I/I |
450,000 |
62,500,000 |
2.25 |
7% |
|
| Casdin Private Growth Equity Fund Gp, Llc |
Director |
– • – |
2025-11-12 |
4 |
B |
$1.19 |
$445,838 |
I/I |
375,000 |
62,050,000 |
2.1 |
8% |
|
| Casdin Private Growth Equity Fund Gp, Llc |
Director |
– • – |
2025-11-11 |
4 |
B |
$1.20 |
$358,800 |
I/I |
300,000 |
61,675,000 |
2.1 |
8% |
|
| Casdin Private Growth Equity Fund Gp, Llc |
Director |
– • – |
2025-11-10 |
4 |
B |
$1.17 |
$321,915 |
I/I |
275,000 |
61,375,000 |
2.1 |
9% |
|
| Casdin Private Growth Equity Fund Gp, Llc |
Director |
– • – |
2025-11-07 |
4 |
B |
$1.12 |
$252,765 |
I/I |
225,000 |
61,100,000 |
2.1 |
13% |
|
| Casdin Eli |
Director |
– • • |
2025-09-09 |
4 |
B |
$1.29 |
$128,920 |
I/I |
100,000 |
60,875,000 |
2.25 |
- |
|
| Casdin Eli |
Director |
– • • |
2025-09-04 |
4 |
B |
$1.28 |
$319,350 |
I/I |
250,000 |
60,775,000 |
2.25 |
-1% |
|
| Casdin Eli |
Director |
– • • |
2025-09-03 |
4 |
B |
$1.27 |
$316,400 |
I/I |
250,000 |
60,525,000 |
2.25 |
-1% |
|
| Casdin Eli |
Director |
– • • |
2025-08-26 |
4 |
B |
$1.26 |
$157,938 |
I/I |
125,000 |
60,275,000 |
2.25 |
-1% |
|
| Casdin Eli |
Director |
– • • |
2025-08-25 |
4 |
B |
$1.24 |
$248,180 |
I/I |
200,000 |
60,150,000 |
2.25 |
3% |
|
| Casdin Eli |
Director |
– • • |
2025-08-22 |
4 |
B |
$1.26 |
$252,680 |
I/I |
200,000 |
59,950,000 |
2.25 |
1% |
|
| Egholm Michael |
President & CEO |
• • – |
2025-08-20 |
4 |
D |
$1.27 |
$69,747 |
D/D |
(54,919) |
5,681,366 |
|
- |
|
684 Records found
|
|
Page 1 of 28 |
|
|
0.03 (2.4%) 
